BIO CEO & Investor Conference 2025

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Organized by the Biotechnology Innovation Organization (BIO), this annual event provides a forum where institutional investors, industry analysts, and senior biotechnology executives can shape the future investment landscape of the biotechnology industry.

The conference covers a broad range of topics, including issue-oriented plenary sessions and discussions focused on hot therapeutic areas and key business issues. Attendees can gain insights during sessions on therapeutic advancements, market outlook, and policy priorities. Additionally, senior-level company executives present their company’s pipeline, R&D activities, business objectives, and investment goals during company presentations.

Practical details of the event include networking opportunities immediately following the day's programs, allowing attendees to meet new partners and reinforce industry relationships. The conference also features the BIO Partnering™ system, a trusted and efficient way to schedule meetings and make connections in the biotech and pharma industry.

The BIO CEO & Investor Conference is ideal for C-level biotech and biopharma executives, institutional investors, venture capitalists, and private equity investors. With 43% of attendees working in biopharma and 75% holding CEO or C-suite positions, the event offers a collaborative forum to learn and exchange ideas about innovation in the biopharma ecosystem.